 Allan Brett
Concepts (182)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pregabalin | 3 | 2019 | 12 | 1.730 |
Why?
| | Analgesics | 3 | 2019 | 231 | 1.470 |
Why?
| | Off-Label Use | 2 | 2019 | 51 | 1.080 |
Why?
| | Pain | 2 | 2019 | 789 | 0.800 |
Why?
| | Ceremonial Behavior | 1 | 2021 | 6 | 0.680 |
Why?
| | Teaching Rounds | 1 | 2021 | 74 | 0.640 |
Why?
| | Hospitals, Voluntary | 1 | 2020 | 9 | 0.630 |
Why?
| | Uncompensated Care | 1 | 2020 | 21 | 0.620 |
Why?
| | Hospitals, Public | 1 | 2020 | 30 | 0.620 |
Why?
| | Pharmacogenetics | 1 | 2021 | 175 | 0.600 |
Why?
| | Neuralgia | 2 | 2019 | 140 | 0.580 |
Why?
| | Education, Medical | 2 | 2021 | 275 | 0.580 |
Why?
| | Aspirin | 1 | 2022 | 406 | 0.560 |
Why?
| | Genetic Testing | 1 | 2021 | 480 | 0.530 |
Why?
| | Cyclohexanecarboxylic Acids | 1 | 2017 | 19 | 0.520 |
Why?
| | Amines | 1 | 2017 | 40 | 0.510 |
Why?
| | Antimicrobial Stewardship | 1 | 2019 | 130 | 0.500 |
Why?
| | Precision Medicine | 1 | 2021 | 459 | 0.480 |
Why?
| | Chronic Pain | 2 | 2019 | 291 | 0.480 |
Why?
| | gamma-Aminobutyric Acid | 1 | 2017 | 194 | 0.460 |
Why?
| | Ambulatory Care | 1 | 2020 | 609 | 0.440 |
Why?
| | Respiratory Tract Infections | 1 | 2019 | 396 | 0.430 |
Why?
| | Sigmoidoscopy | 1 | 2014 | 14 | 0.430 |
Why?
| | Fluoroquinolones | 1 | 2013 | 44 | 0.400 |
Why?
| | Foramen Ovale, Patent | 1 | 2013 | 11 | 0.390 |
Why?
| | Coronary Disease | 3 | 2005 | 381 | 0.380 |
Why?
| | Septal Occluder Device | 1 | 2013 | 37 | 0.380 |
Why?
| | Retinal Detachment | 1 | 2013 | 73 | 0.380 |
Why?
| | Cardiovascular Diseases | 3 | 2022 | 2187 | 0.370 |
Why?
| | Physician-Patient Relations | 3 | 2012 | 588 | 0.360 |
Why?
| | Ethics, Professional | 1 | 2012 | 14 | 0.360 |
Why?
| | Secondary Prevention | 1 | 2013 | 251 | 0.350 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2019 | 919 | 0.350 |
Why?
| | Unnecessary Procedures | 1 | 2012 | 54 | 0.340 |
Why?
| | Prostate-Specific Antigen | 1 | 2011 | 161 | 0.330 |
Why?
| | Telemedicine | 1 | 2020 | 961 | 0.320 |
Why?
| | Primary Health Care | 1 | 2021 | 1735 | 0.320 |
Why?
| | Fibrinolytic Agents | 1 | 2013 | 297 | 0.320 |
Why?
| | Social Values | 2 | 2009 | 40 | 0.310 |
Why?
| | Practice Guidelines as Topic | 3 | 2019 | 1581 | 0.310 |
Why?
| | Single-Payer System | 1 | 2009 | 2 | 0.300 |
Why?
| | Patient Preference | 1 | 2012 | 223 | 0.290 |
Why?
| | Stroke | 2 | 2013 | 1270 | 0.290 |
Why?
| | Early Detection of Cancer | 1 | 2014 | 485 | 0.290 |
Why?
| | United States | 13 | 2022 | 16098 | 0.290 |
Why?
| | Case Management | 1 | 2009 | 68 | 0.280 |
Why?
| | Health Care Reform | 1 | 2009 | 109 | 0.270 |
Why?
| | United States Food and Drug Administration | 2 | 2021 | 208 | 0.270 |
Why?
| | Drug Approval | 2 | 2019 | 93 | 0.270 |
Why?
| | Schools, Medical | 1 | 2009 | 159 | 0.260 |
Why?
| | Humans | 30 | 2022 | 145474 | 0.260 |
Why?
| | Anti-Bacterial Agents | 2 | 2019 | 1923 | 0.260 |
Why?
| | Thiazolidinediones | 1 | 2007 | 139 | 0.240 |
Why?
| | Colorectal Neoplasms | 1 | 2014 | 866 | 0.240 |
Why?
| | Advisory Committees | 2 | 2022 | 229 | 0.240 |
Why?
| | Managed Care Programs | 2 | 1999 | 140 | 0.240 |
Why?
| | Neuraminidase | 1 | 2005 | 25 | 0.230 |
Why?
| | Education, Medical, Undergraduate | 1 | 2009 | 207 | 0.230 |
Why?
| | Preventive Health Services | 2 | 2022 | 153 | 0.230 |
Why?
| | Acetamides | 1 | 2005 | 41 | 0.230 |
Why?
| | Drug Resistance, Viral | 1 | 2005 | 126 | 0.220 |
Why?
| | Prostatic Neoplasms | 1 | 2011 | 978 | 0.210 |
Why?
| | Medical Records | 2 | 2021 | 192 | 0.200 |
Why?
| | Drug Prescriptions | 1 | 2005 | 288 | 0.200 |
Why?
| | Mass Screening | 1 | 2011 | 1360 | 0.190 |
Why?
| | Vascular Surgical Procedures | 1 | 2005 | 343 | 0.170 |
Why?
| | HLA-B15 Antigen | 1 | 2021 | 12 | 0.170 |
Why?
| | Carbamazepine | 1 | 2021 | 24 | 0.170 |
Why?
| | Allopurinol | 1 | 2021 | 70 | 0.170 |
Why?
| | HLA-B Antigens | 1 | 2021 | 58 | 0.160 |
Why?
| | Pravastatin | 1 | 2000 | 45 | 0.160 |
Why?
| | Cardiovascular System | 1 | 2022 | 138 | 0.160 |
Why?
| | Anticholesteremic Agents | 2 | 2000 | 155 | 0.160 |
Why?
| | Tax Exemption | 1 | 2020 | 7 | 0.160 |
Why?
| | Drug Misuse | 1 | 2019 | 2 | 0.160 |
Why?
| | Physical Examination | 1 | 2021 | 243 | 0.150 |
Why?
| | Influenza, Human | 1 | 2005 | 624 | 0.150 |
Why?
| | Sciatica | 1 | 2019 | 8 | 0.150 |
Why?
| | Minimal Clinically Important Difference | 1 | 2019 | 31 | 0.150 |
Why?
| | Patient Protection and Affordable Care Act | 1 | 2020 | 103 | 0.150 |
Why?
| | Neuralgia, Postherpetic | 1 | 2019 | 40 | 0.140 |
Why?
| | Radiculopathy | 1 | 2019 | 38 | 0.140 |
Why?
| | Insurance Claim Reporting | 1 | 1998 | 26 | 0.140 |
Why?
| | Policy | 1 | 2020 | 148 | 0.140 |
Why?
| | Fibromyalgia | 1 | 2019 | 52 | 0.140 |
Why?
| | Diabetic Neuropathies | 1 | 2019 | 100 | 0.130 |
Why?
| | Hypoglycemic Agents | 1 | 2007 | 1399 | 0.130 |
Why?
| | Low Back Pain | 1 | 2019 | 107 | 0.130 |
Why?
| | Cost-Benefit Analysis | 2 | 2012 | 639 | 0.130 |
Why?
| | C-Reactive Protein | 1 | 2019 | 422 | 0.120 |
Why?
| | Guidelines as Topic | 1 | 1998 | 266 | 0.120 |
Why?
| | Inappropriate Prescribing | 1 | 2017 | 66 | 0.120 |
Why?
| | Pain Measurement | 1 | 2019 | 561 | 0.120 |
Why?
| | Drug Utilization | 1 | 2017 | 168 | 0.120 |
Why?
| | Poverty | 1 | 2020 | 526 | 0.120 |
Why?
| | Medicaid | 1 | 2020 | 467 | 0.110 |
Why?
| | Spinal Cord Injuries | 1 | 2019 | 234 | 0.110 |
Why?
| | Hospitals | 1 | 2020 | 732 | 0.110 |
Why?
| | Decision Making | 5 | 2012 | 977 | 0.110 |
Why?
| | Communication | 1 | 2021 | 975 | 0.110 |
Why?
| | Personal Autonomy | 2 | 2012 | 59 | 0.110 |
Why?
| | Adrenergic beta-Agonists | 1 | 2013 | 92 | 0.100 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2007 | 2588 | 0.090 |
Why?
| | Medicare | 1 | 1998 | 903 | 0.090 |
Why?
| | Bronchodilator Agents | 1 | 2013 | 187 | 0.090 |
Why?
| | Data Collection | 2 | 2009 | 640 | 0.090 |
Why?
| | Health Maintenance Organizations | 1 | 1992 | 105 | 0.090 |
Why?
| | Direct Service Costs | 1 | 2011 | 9 | 0.090 |
Why?
| | Sinusitis | 1 | 1994 | 227 | 0.080 |
Why?
| | Attitude of Health Personnel | 1 | 1999 | 1193 | 0.080 |
Why?
| | Resuscitation Orders | 1 | 1991 | 48 | 0.080 |
Why?
| | Anti-Asthmatic Agents | 1 | 2013 | 260 | 0.080 |
Why?
| | Withholding Treatment | 1 | 1991 | 80 | 0.080 |
Why?
| | Health Resources | 1 | 2012 | 130 | 0.080 |
Why?
| | Advance Directives | 1 | 1991 | 88 | 0.080 |
Why?
| | Adrenal Cortex Hormones | 1 | 2013 | 484 | 0.080 |
Why?
| | Public Opinion | 2 | 2009 | 62 | 0.080 |
Why?
| | Health Policy | 1 | 1993 | 400 | 0.080 |
Why?
| | Ethics, Medical | 3 | 1992 | 90 | 0.080 |
Why?
| | Anti-Inflammatory Agents | 1 | 2013 | 477 | 0.080 |
Why?
| | Lobbying | 1 | 2009 | 3 | 0.080 |
Why?
| | Private Sector | 1 | 2009 | 50 | 0.070 |
Why?
| | Diagnosis, Differential | 1 | 1993 | 1508 | 0.070 |
Why?
| | Hypercholesterolemia | 1 | 1989 | 95 | 0.070 |
Why?
| | Choice Behavior | 1 | 2009 | 180 | 0.070 |
Why?
| | Emergency Service, Hospital | 1 | 2020 | 2381 | 0.070 |
Why?
| | Practice Patterns, Physicians' | 2 | 2007 | 1371 | 0.060 |
Why?
| | Patient Participation | 2 | 1991 | 439 | 0.060 |
Why?
| | Therapeutics | 1 | 1986 | 14 | 0.060 |
Why?
| | Insurance, Health | 1 | 2009 | 310 | 0.060 |
Why?
| | Male | 5 | 2014 | 72842 | 0.060 |
Why?
| | Patient Advocacy | 1 | 1986 | 73 | 0.060 |
Why?
| | Oseltamivir | 1 | 2005 | 17 | 0.060 |
Why?
| | Risk Assessment | 2 | 2013 | 3747 | 0.060 |
Why?
| | Angioplasty, Balloon, Coronary | 1 | 2005 | 156 | 0.050 |
Why?
| | Internet | 1 | 2009 | 689 | 0.050 |
Why?
| | Risk Factors | 4 | 2013 | 10885 | 0.050 |
Why?
| | Physician's Role | 1 | 2005 | 223 | 0.050 |
Why?
| | Coronary Artery Bypass | 1 | 2005 | 268 | 0.050 |
Why?
| | Preoperative Care | 1 | 2005 | 380 | 0.050 |
Why?
| | Female | 4 | 2014 | 78844 | 0.040 |
Why?
| | Asthma | 1 | 2013 | 1797 | 0.040 |
Why?
| | Curriculum | 1 | 2009 | 1070 | 0.040 |
Why?
| | Life Support Care | 2 | 1992 | 42 | 0.040 |
Why?
| | Conflict of Interest | 1 | 1999 | 54 | 0.040 |
Why?
| | Fraud | 1 | 1998 | 11 | 0.040 |
Why?
| | Insurance, Health, Reimbursement | 1 | 1998 | 98 | 0.030 |
Why?
| | Blood Glucose | 1 | 2007 | 2341 | 0.030 |
Why?
| | Algorithms | 1 | 2005 | 1845 | 0.030 |
Why?
| | Documentation | 1 | 1998 | 199 | 0.030 |
Why?
| | Surveys and Questionnaires | 1 | 2009 | 6066 | 0.030 |
Why?
| | Insurance Pools | 1 | 1993 | 1 | 0.030 |
Why?
| | Competitive Medical Plans | 1 | 1993 | 1 | 0.030 |
Why?
| | National Health Insurance, United States | 1 | 1993 | 5 | 0.030 |
Why?
| | Hepatitis, Alcoholic | 1 | 1993 | 16 | 0.020 |
Why?
| | Ethics, Institutional | 1 | 1992 | 4 | 0.020 |
Why?
| | Persuasive Communication | 1 | 1992 | 14 | 0.020 |
Why?
| | Drug Combinations | 1 | 2013 | 396 | 0.020 |
Why?
| | Administration, Inhalation | 1 | 2013 | 571 | 0.020 |
Why?
| | Consent Forms | 1 | 1991 | 12 | 0.020 |
Why?
| | Living Wills | 1 | 1991 | 9 | 0.020 |
Why?
| | Continuity of Patient Care | 1 | 1993 | 297 | 0.020 |
Why?
| | Odds Ratio | 1 | 2013 | 1082 | 0.020 |
Why?
| | Uncertainty | 1 | 1991 | 146 | 0.020 |
Why?
| | Patient Safety | 1 | 2013 | 356 | 0.020 |
Why?
| | Carcinoma, Hepatocellular | 1 | 1993 | 372 | 0.020 |
Why?
| | Technology, High-Cost | 1 | 1986 | 1 | 0.020 |
Why?
| | Probability | 2 | 1992 | 307 | 0.020 |
Why?
| | Incidence | 1 | 2013 | 2923 | 0.020 |
Why?
| | Liver Neoplasms | 1 | 1993 | 776 | 0.020 |
Why?
| | Consumer Behavior | 1 | 1986 | 69 | 0.010 |
Why?
| | Decision Theory | 1 | 1981 | 2 | 0.010 |
Why?
| | Diet | 1 | 1989 | 1277 | 0.010 |
Why?
| | Patients | 1 | 1981 | 183 | 0.010 |
Why?
| | Mortality | 1 | 1981 | 378 | 0.010 |
Why?
| | Surgical Procedures, Operative | 1 | 1981 | 271 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2013 | 11772 | 0.010 |
Why?
| | Adult | 2 | 2013 | 40777 | 0.010 |
Why?
| | Health Care Rationing | 1 | 1992 | 56 | 0.010 |
Why?
| | Organ Transplantation | 1 | 1992 | 251 | 0.000 |
Why?
| | Cardiopulmonary Resuscitation | 1 | 1992 | 338 | 0.000 |
Why?
| | Quality of Life | 1 | 1992 | 3204 | 0.000 |
Why?
|
|
Brett's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|